Pharmaceutical News

RSS

Long-term aspirin therapy shows no benefit for stroke reduction in low risk AF patients, study finds

A new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City found that using long-term aspirin therapy to prevent strokes among patients who are considered to be at low risk for stroke may not be effective as previously thought.

15 May 2017

Delayed anticoagulation treatment for atrial fibrillation patients increases dementia risk, study finds

A new study has found that dementia rates increase when anticoagulation treatment is delayed for patients with atrial fibrillation, the most common heart arrhythmia in the world that affects more than 2.7 million American adults.

12 May 2017

Zinc acetate lozenges may provide 3-fold increase in recovery rate from common cold

According to a meta-analysis of three randomized controlled trials published in Open Forum Infectious Diseases, zinc acetate lozenges may increase the rate of recovery from the common cold three fold. On the fifth day, 70% of the zinc lozenge patients had recovered compared with 27% of the placebo patients.

11 May 2017

Breast cancer drug offers protection against obesity-related metabolic disorders

Tamoxifen, a selective estrogen receptor modulator, is the gold standard for endocrine treatment of estrogen-receptor positive breast cancer.

11 May 2017

Boosting clinical trial research in London

Richmond Pharmacology have opened their fourth clinical trial facility and the new site has been used for this type of work for more than 30 years. It's in an ideal location embedded in the University and teaching hospital campus.

11 May 2017

New electrochemical method can remove extremely low levels of pollutants from water

When it comes to removing very dilute concentrations of pollutants from water, existing separation methods tend to be energy- and chemical-intensive. Now, a new method developed at MIT could provide a selective alternative for removing even extremely low levels of unwanted compounds.

10 May 2017

Anti-smoking drug safe for COPD patients, research suggests

Medication that helps smokers to quit is safe for use by people with chronic lung conditions, research suggests.

10 May 2017

Serum Institute signs licensing agreement to commercialize St. Jude vaccine against RSV

St. Jude Children's Research Hospital and the Serum Institute of India have signed a licensing agreement to complete development and commercialization of a St. Jude vaccine against the respiratory syncytial virus (RSV), the virus that causes croup and lower respiratory infections. RSV kills about 160,000 people, primarily infants, worldwide each year.

10 May 2017

Regular use of common painkillers increases risk of heart attack, study reports

A study published in the British Medical Journal suggests that when people use commonly prescribed non-steroidal anti-inflammatory drugs (NSAIDs) for treating pain and inflammation, the risk of heart attack increases as early as in the first week of consumption and particularly within the first month of using such medication in high doses.

10 May 2017

Lamaty employs Uniqsis FlowSyn Multi-X system to achieve efficient ring closing olefin metathesis

Uniqsis has published details of a new flow-through protocol developed by the Lamaty Group at Universite de Montpellier on a FlowSyn™ Multi-X system that provides efficient ring closing olefin metathesis.

10 May 2017

Swiss researchers discover potential way to design new antibiotics

Two Swiss research teams from the University of Bern and the ETH Zurich have developed a new method to shed light onto a mostly unknown process of bacterial protein production. Their results could be used for the design of new antibiotics.

10 May 2017

Natural compound in grape seed extract could increase strength, life of composite-resin fillings

A natural compound found in grape seed extract could be used to strengthen dentin -- the tissue beneath a tooth's enamel -- and increase the life of resin fillings, according to new research at the University of Illinois at Chicago College of Dentistry.

10 May 2017

Two widely used drugs show effectiveness in treating patients with CRVO-associated macular edema

Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the treatment of central retinal vein occlusion, according to a clinical trial funded by the National Eye Institute, part of the National Institutes of Health.

10 May 2017

Scientists aim to revolutionize asthma treatment by replacing inhalers with new drug

A common treatment for asthma, which is the most prevalent chronic childhood disease, requires use of an inhaler. But a big problem with inhalers, used to deliver steroids and other drugs in an aerosol form, is that children often don't operate them properly.

10 May 2017

Three TSRI scientists receive awards from Royal Society of Chemistry

Three chemists from The Scripps Research Institute- Dale Boger, Jin-Quan Yu and Phil Baran- have received awards from the Royal Society of Chemistry, a renowned professional organization for chemists based in the United Kingdom, with more than 54,000 members worldwide.

10 May 2017

Study finds high rate of unnecessary antibiotic prescribing for low-risk Ontarian seniors

Nearly one in two seniors in Ontario who visited a family doctor for a non-bacterial infection received an unnecessary antibiotic prescription, according to a new study from the Institute for Clinical Evaluative Sciences Western site in London, Ontario and Lawson Health Research Institute.

9 May 2017

Researchers find many postmarket safety events after FDA approval of new drugs

How often are safety concerns raised about a drug after it's been approved by the FDA? Nicholas Downing, MD, of the Department of Medicine at Brigham and Women's Hospital, and colleagues have found that for drugs approved between 2001 and 2010, nearly 1 in 3 had a postmarket safety event.

9 May 2017

BGRF scientists help develop AI to expedite drug development for age-related conditions

The Chief Science Officer of the Biogerontology Research Foundation will present new research on artificial intelligence for drug discovery at the NVIDIA Graphics Technology Conference at the San Jose Convention Center, on Wednesday, May 10, 1:00 PM - 1:50 PM alongside two AI scientists from the BGRF and Insilico Medicine, where they will deliver a presentation titled "Applications of Generative Adversarial Networks to Drug Discovery in Oncology and Infectious Diseases".

9 May 2017

Novel nanoscale molecular slingshot could ‘shoot’ and deliver drugs at precise disease locations

An international team of researchers from the University of Rome Tor Vergata and the University of Montreal has reported, in a paper published this week in Nature Communications, the design and synthesis of a nanoscale molecular slingshot made of DNA that is 20,000 times smaller than a human hair.

9 May 2017

PTSD and psychoactive drugs linked to increased risk for dementia

Researchers are discovering that post-traumatic stress disorder (PTSD) is a significant risk factor in developing dementia.

9 May 2017

Pharmaceutical News

Long-term aspirin therapy shows no benefit for stroke reduction in low risk AF patients, study finds

Delayed anticoagulation treatment for atrial fibrillation patients increases dementia risk, study finds

Zinc acetate lozenges may provide 3-fold increase in recovery rate from common cold

Breast cancer drug offers protection against obesity-related metabolic disorders

Boosting clinical trial research in London

New electrochemical method can remove extremely low levels of pollutants from water

Anti-smoking drug safe for COPD patients, research suggests

Serum Institute signs licensing agreement to commercialize St. Jude vaccine against RSV

Regular use of common painkillers increases risk of heart attack, study reports

Lamaty employs Uniqsis FlowSyn Multi-X system to achieve efficient ring closing olefin metathesis

Swiss researchers discover potential way to design new antibiotics

Natural compound in grape seed extract could increase strength, life of composite-resin fillings

Two widely used drugs show effectiveness in treating patients with CRVO-associated macular edema

Scientists aim to revolutionize asthma treatment by replacing inhalers with new drug

Three TSRI scientists receive awards from Royal Society of Chemistry

Study finds high rate of unnecessary antibiotic prescribing for low-risk Ontarian seniors

Researchers find many postmarket safety events after FDA approval of new drugs

BGRF scientists help develop AI to expedite drug development for age-related conditions

Novel nanoscale molecular slingshot could ‘shoot’ and deliver drugs at precise disease locations

PTSD and psychoactive drugs linked to increased risk for dementia

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News